Shuichi Shirane
Overview
Explore the profile of Shuichi Shirane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Shirane S, Watanabe D, Sekiya N, Horiguchi S, Najima Y
Int J Infect Dis
. 2021 Oct;
113:210-212.
PMID: 34656786
No abstract available.
22.
Kinoshita S, Ando M, Ando J, Ishii M, Furukawa Y, Tomita O, et al.
Heliyon
. 2021 Aug;
7(8):e07804.
PMID: 34458631
Trio-next generation sequencing is useful to identify undiagnosed inherited diseases. We have attended a patient with trigenic // pathogenic variants, which caused two distinct diseases, myelodysplastic syndrome and Usher syndrome....
23.
Edahiro Y, Takaku T, Suzuki M, Fukuda Y, Harada S, Kinoshita S, et al.
Leuk Res Rep
. 2021 Jun;
15:100249.
PMID: 34136342
We report about a 48-year-old woman diagnosed with primary central nervous system lymphoma (PCNSL). After chemotherapy and autologous stem cell transplantation, she presented with a continuous high-grade fever. Positron emission...
24.
Shirane S, Hamano Y, Furuya C, Honda T, Sasaki M, Komatsu N
Rinsho Ketsueki
. 2021 Mar;
62(2):85-90.
PMID: 33678775
We report the case of a 58-year-old woman with multiple myeloma who relapsed after the first autologous peripheral blood stem cell transplantation. She was refractory to new drugs and underwent...
25.
Yamashita Y, Takahashi Y, Tsunemi T, Shirane S, Nakazato-Taniguchi T, Taniguchi D, et al.
Can J Neurol Sci
. 2020 Sep;
48(3):446-449.
PMID: 32959744
No abstract available.
26.
Murata M, Suzuki R, Nishida T, Shirane S, Shimazu Y, Minami Y, et al.
Intern Med
. 2020 Aug;
59(16):1947-1956.
PMID: 32801269
Objective Little information is available about the outcome of allogeneic hematopoietic stem cell transplantation (HSCT) for patients with secondary myelofibrosis from essential thrombocythemia (ET) and polycythemia vera (PV). A nationwide...
27.
Kurosawa S, Doki N, Senoo Y, Kishida Y, Nagata A, Yamada Y, et al.
Ann Hematol
. 2020 May;
99(8):1873-1882.
PMID: 32451708
Bone turnover markers (BTMs) are useful parameters for assessing fracture risk and unlike bone mineral density (BMD), can be measured at any institution. However, BTM values have not been established...
28.
Uchida T, Doki N, Kishida Y, Nagata A, Yamada Y, Konishi T, et al.
Rinsho Ketsueki
. 2020 Feb;
61(1):11-19.
PMID: 32023596
There have been many reports regarding tyrosine kinase inhibitor (TKI) administration to prevent relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)....
29.
Kurosawa S, Sekiya N, Doki N, Yaguchi T, Kishida Y, Nagata A, et al.
Int J Infect Dis
. 2019 Oct;
89:154-162.
PMID: 31605809
Objective: The purpose of this study was to describe the clinical features of nocardiosis after allogeneic hematopoietic stem cell transplantation (allo-HSCT), focusing on new Nocardia species. Methods: We retrospectively reviewed...
30.
Yasuda H, Tsutsui M, Ando J, Inano T, Noguchi M, Yahata Y, et al.
Int J Hematol
. 2019 Aug;
110(5):543-549.
PMID: 31407257
Vitamin B6 (VB6) deficiency contributes to oncogenesis and tumor progression in certain cancers, and is prevalent in cancer patients in general. VB6 is also an essential element of heme synthesis,...